Two years in the making, we have posted our NINDS 2021-2026 Strategic Plan. This Strategic Plan differs from its predecessors in several ways. First, it began with a mandate that my colleagues at NINDS dream big. Big for patients and families struggling everyday with neurological disorders. Big for scientists around the world trying to understand the mysteries of the brain, spinal cord, muscles, and peripheral nerves. Big for the clinical trialists, the pharmaceutical industry, the science and technology policy makers, the device inventors. Big for health, quality of life, safety, rigor, and public access.
Second, it started within NINDS, with 100 taskforce and steering committee members and nearly 100 intramural faculty, staff, and trainees; then our outside stakeholders, with 140 discussion panel members; and finally more than 120 responses from individuals and organizations to requests for information from the public. Developing the plan empowered our biomedical workforce, engaged patients and advocacy groups, reached out to industry, academia, and our colleagues in government.
Third, it includes both focused approaches to our science and our training programs, and broad, overarching strategies that are part of the fabric of who we are and who we hope to be. That hope is to be the very best possible version of NINDS and to serve as a model and impetus for the entire biomedical community to become their best, too.Continue reading “Announcing the New NINDS Five-year Strategic Plan”